Salivary gland tumor overview

Jump to navigation Jump to search

Salivary gland tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Salivary gland tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Fine-needle Aspiration Biopsy (FNAB)

Head X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Salivary gland tumor overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Salivary gland tumor overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Salivary gland tumor overview

CDC on Salivary gland tumor overview

Salivary gland tumor overview in the news

Blogs on Salivary gland tumor overview

Directions to Hospitals Treating Salivary gland tumor

Risk calculators and risk factors for Salivary gland tumor overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Salivary gland cancer is a cancer that forms in the tissues of a salivary gland. The salivary glands are classified as major and minor. The major salivary glands consist of the parotid, submandibular, and sublingual glands. The minor glands include small mucus-secreting glands located throughout the palate, nasal, and oral cavity. Salivary gland cancer is rare, with 2% of head and neck tumors forming in the salivary glands, the majority in the parotid.[1] Salivary gland tumor may be classified according to World Health Organization into five groups: malignant epithelial tumors, benign epithelial tumors, soft tissue tumors, hematolymphoid tumors, and secondary tumors.[1] The pathophysiology of salivary gland tumors depends on the histological subtype.[2] There are no established causes of salivary gland tumors. The incidence of salivary gland tumors is approximately 2.5 cases to 3.0 cases per 100, 000 individuals worldwide. The incidence of salivary gland tumors is estimated to be 2000 to 2500 cases per year in the United States. The incidence of salivary gland tumors increases with age; the median age at diagnosis is 64 years. Salivary gland tumors are more common in males than females. There is no racial predilection to the salivary gland tumors.[3] Common risk factors in the development of salivary gland tumors are age, radiation exposure, environment and occupational exposure, certain viruses, male gender, smoking, and family history.[4] Symptoms of salivary gland tumor include, difficulty swallowing, muscle weakness on one side of the face, a lump or swelling on or near the jaw or in the neck or mouth, numbness in part of the face, persistent pain in the area of a salivary gland and trouble opening the mouth widely. The optimal therapy for salivary gland tumors depends on the stage at diagnosis. The mainstay of therapy for salivary gland tumors is surgery. External beam radiation therapy may be used following surgery, or when surgery is not possible or would cause significant complications. Chemotherapy is considered when radiation therapy or surgery is refused.

Classification

Salivary gland tumor may be classified according to World Health Organization into five groups: malignant epithelial tumors, benign epithelial tumors, soft tissue tumors, hematolymphoid tumors, and secondary tumors.[1]

Pathophysiology

The pathophysiology of salivary gland tumors depends on the histological subtype.[2]

Causes

There are no established causes of salivary gland tumors.

Differential Diagnosis

Salivary gland tumor must be differentiated from other diseases that cause a salivary gland mass or enlargement such as salivary cysts, cysts of the first branchial cleft, salivary gland stones, sarcoid infiltration of the parotid gland, Sjogren's syndrome, metastasis from other tumors, lymphoepithelial cysts, chronic sclerosing sialadenitis, regional lymphadenopathy, Bell's palsy, and intraparotid facial nerve schwannoma.

Epidemiology and Demographics

The incidence of salivary gland tumors is approximately 2.5 cases to 3.0 cases per 100, 000 individuals worldwide. The incidence of salivary gland tumors is estimated to be 2000 to 2500 cases per year in the United States. The incidence of salivary gland tumors increases with age; the median age at diagnosis is 64 years. Salivary gland tumors are more common in males than females. There is no racial predilection to the salivary gland tumors.[3]

Risk Factors

Common risk factors in the development of salivary gland tumors are age, radiation exposure, environment and occupational exposure, certain viruses, male gender, smoking and family history.[4]

Screening

According to the United States Preventive Services Task Force, screening for salivary gland tumors is not recommended.[5]

Natural History, Complications and Prognosis

If left untreated, patients with salivary gland tumors may progress to develop metastasis. Common complications of salivary gland tumors include metastasis and injury to the facial nerve. Prognosis is generally good, and the 5 year mortality rate of patients with salivary gland cancer that has not spread at the time of diagnosis is 91%.

Staging

According to the TNM staging system by the American Joint Committee on Cancer, there are four stages of salivary gland cancers based on the tumor size, lymph nodes involved, and metastasis.

History and Symptoms

Symptoms of salivary gland tumor include, difficulty swallowing, muscle weakness on one side of the face, a lump or swelling on or near the jaw or in the neck or mouth, numbness in part of the face, persistent pain in the area of a salivary gland and trouble opening the mouth widely.

Physical Examination

Common physical examination findings of salivary gland cancer include painless, firm swelling in one of the salivary gland, cervical lymphadenopathy, difficulty swallowing, trouble opening the mouth widely, difficulty moving one side of the face and muscle weakness on one side of the face suggestive of cranial nerve VII deficit, and loss of corneal reflex, localized or regional pain, numbness, paresthesia, causalgia, or a loss of motor function suggestive of loss of cranial nerve V deficit.[4]

Laboratory Findings

There are no established lab findings associated with salivary gland tumors.

Fine Needle Aspiration Biopsy (FNAB)

Biopsy of the tumor tissue is diagnostic of salivary gland tumor. Histopathological findings on biopsy can be found here.

Head X ray

X-rays of jaw and teeth may be diagnostic of salivary gland tumor.

CT

Head and neck CT scan may be helpful in the diagnosis of salivary gland tumors. Findings on CT scan suggestive of salivary gland tumors include bony, local and, perineural invasion and lymph node metastasis.

MRI

Head and neck MRI may be helpful in the diagnosis of salivary gland tumors. Findings on head and neck MRI suggestive of salivary gland tumors include soft tissue infiltration, perineural invasion, and intracranial extention.[4]

Ultrasound

Ultrasound may be helpful in the diagnosis of salivary gland tumors. Findings on ultrasound suggestive of salivary gland tumors include typically hypoechoic mass with lobulated distinct border with or without posterior acoustic enhancement. Ultrasound is also useful in guiding biopsy including FNAC and core biopsies.[6]

Other Imaging Studies

Other imaging studies for salivary gland tumor include PET scan and endoscopy.[4]

Other Diagnostic Studies

There are no other diagnostic studies associated with salivary gland tumors.

Medical Therapy

The optimal therapy for salivary gland tumors depends on the stage at diagnosis. The mainstay of therapy for salivary gland tumors is surgery. External beam radiation therapy may be used following surgery, or when surgery is not possible or would cause significant complications. Chemotherapy is considered when radiation therapy or surgery is refused.

Surgery

The mainstay of therapy for salivary gland tumor is surgery.

Primary Prevention

Effective measures for the primary prevention of salivary gland tumors include avoiding some of the possible risk factors such as tobacco, excess alcohol use, and unhealthy diets.

Secondary Prevention

Secondary prevention strategies following salivary gland cancer include follow-up visits every 6-8 weeks for first year, every 2-3 months in the second year, every 3-4 months in the third year, and then every 6-12 months for life.

References

  1. 1.0 1.1 1.2 Salivary gland neoplasm. Wikipedia(2015) https://en.wikipedia.org/wiki/Salivary_gland_neoplasm Accessed on November 8, 2015
  2. 2.0 2.1 Salivary glands. Libre pathology(2015) http://librepathology.org/wiki/index.php/Salivary_glands Accessed on November 11, 2015
  3. 3.0 3.1 Salivary gland cancer. National cancer Institute(2015) http://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq#link/_403_toc Accessed on November 7, 2015
  4. 4.0 4.1 4.2 4.3 4.4 Salivary gland cancer. Canadian cancer society(2015)http://www.cancer.ca/en/cancer-information/cancer-type/salivary-gland/risks/?region=sk Accessed on November 8, 2015
  5. http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=salivary+gland+tumor Accessed on November 11, 2015.
  6. Salivary gland cancer. Radiopedia(2015)http://radiopaedia.org/articles/pleomorphic-adenoma-of-the-salivary-glands Accessed on November 8, 2015

Template:WikiDoc Sources